Patent US5554643A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5554643A Expired / Lapsed US ⏱️ 0.0 years remaining

Pro-drugs for CCK antagonists

Assignee: Warner Lambert Co LLC
•
Filing: 1994-04-13
•
Granted: 1996-09-10
•
Expires: 2014-04-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel pro-drugs to new and unnatural depeptoids of α-substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further, the dipeptoids are antianxiety agents and antiulcer agents. They are agents useful for preventing the response to the withdrawal from chronic treatment or with use of nicotine, diazepam, alcohol, cocaine, caffeine, or opioids. The pro-drugs are also useful in treating and/or preventing panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the pro-drugs as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject pro-drug compounds in diagnostic compositions.

Inventors

  • 👤 David C. Horwell
  • 👤 Martyn C. Pritchard
  • 👤 Reginald S. Richardson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 23:55
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/12; A; A61; A61P; A61P1/00; A61P1/04; A61P25/00; A61P3/00; A61P3/04; A61P43/00; C07D209/00; C07D209/02; C07D209/04; C07D209/10; C07D209/14; C07K; C07K5/00; C07K5/02; C07K5/0202; C07K5/0205; C07K5/0207; C07K5/021; C07K5/04; C07K5/08; C07K5/0821; A61K; A61K38/00

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 613 words
A compound of the formula ##STR39## or a pharmaceutically acceptable salt thereof wherein: R 1 is a cycloalkyl or polycycloalkyl hydrocarbon of from three to twelve carbon atoms with from zero to four substituents each independently selected from the group consisting of a straight or branched alkyl of from one to about six carbon atoms, halogen, CN, OR*, SR*, CO 2 R*, CF 3 , NR 5 R 6 , and --(CH 2 ) n OR 5 wherein R* is hydrogen, straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n Ar, --COAr, --(CH 2 ) n OCOAr, or --(CH 2 ) n NR 5 COAr and R* may also independently be R** as defined below, and R** must be present once in formula I, and R** is attached to formula I through a metabolically labile bond, R 5 and R 6 are each independently hydrogen or alkyl of from one to six carbon atoms and n is an integer from zero to six; and R** is --(CH 2 ) n NR 5 R 6 , --(CH 2 ) n --B--D* wherein D* is O--COR*, CO 2 Ar 2 , (CH 2 ) n Ar 2 , OCOAr 2 , NR 5 COAr 2 , COAr 2 , CO 2 CH(R)--CO 2 R*, CO 2 --(CH 2 ) n OCOR* where Ar 2 is independently taken from Ar, where m is as defined below, CONHCH(R)CO 2 R* where R is a side chain of aspartic or glutamic acid, R is hydrogen only when B is not a bond, --CO 2 CH 2 CH 2 N + (R*) 3 X 1- when X 1- is a pharmaceutically acceptable counter anion, A is --(CH 2 ) n CO--, --SO 2 --, --S(═O)--, --NHCO--, --(CH 2 ) n --C(═O)--, ##STR40## --O--(CH 2 ) n CO-- or --HC═CHCO-- wherein n is an integer from zero to six; R 2 is CH 3 ; R 3 and R 4 are each independently selected from hydrogen, R 2 and --(CH 2 ) n , --B--D wherein: n' is an integer of from zero to three; B is a bond, --OCO(CH 2 ) n --, --O(CH 2 ) n --, --NHCO(CH 2 ) n --, --CONH(CH 2 ) n --, --NHCOCH═CH--, --COO(CH 2 ) n --, --CO(CH 2 ) n --, --S--(CH 2 ) n --, --S(═)--(CH 2 ) n --, --SO 2 --(CH 2 ) n --, --NHSO 2 --(CH 2 ) n --, --SO 2 NH--(CH 2 ) n --, ##STR41## wherein R 7 and R 8 are each independently selected from hydrogen and R 2 or together form a ring (CH 2 ) m wherein m is an integer of from 1 to 5 and n is as defined above; D is hydrogen, --COOR*, --CH 2 NR 5 R*, --CHR 2 NR 5 R*, --CH 2 OR*, --CHR 2 OR*, --CH 2 SR*, --CHR 2 SR*, --CONR 5 R 6 , --CONR 5 R*, an acid replacement selected from ##STR42## wherein R*, R 2 , R 5 , and R 6 are as defined above; R 9 is hydrogen or a straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n CO 2 R*, --(CH 2 ) n NR 5 R*, wherein n, R * , and R 5 are as defined above or taken from R 3 ; R 12 and R 13 are each independently hydrogen or are each independently taken with R 3 and R 4 , respectively, to form a moiety doubly bonded to the carbon atom; and Ar is a mono- or polycyclic unsubstituted or substituted carbo- aromatic or carbo- hydroaromatic moiety.
Claim 2
Dependent Claim 613 words
A compound of the formula ##STR39## or a pharmaceutically acceptable salt thereof wherein: R 1 is a cycloalkyl or polycycloalkyl hydrocarbon of from three to twelve carbon atoms with from zero to four substituents each independently selected from the group consisting of a straight or branched alkyl of from one to about six carbon atoms, halogen, CN, OR*, SR*, CO 2 R*, CF 3 , NR 5 R 6 , and --(CH 2 ) n OR 5 wherein R* is hydrogen, straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n Ar, --COAr, --(CH 2 ) n OCOAr, or --(CH 2 ) n NR 5 COAr and R* may also independently be R** as defined below, and R** must be present once in formula I, and R** is attached to formula I through a metabolically labile bond, R 5 and R 6 are each independently hydrogen or alkyl of from one to six carbon atoms and n is an integer from zero to six; and R** is --(CH 2 ) n NR 5 R 6 , --(CH 2 ) n --B--D* wherein D* is O--COR*, CO 2 Ar 2 , (CH 2 ) n Ar 2 , OCOAr 2 , NR 5 COAr 2 , COAr 2 , CO 2 CH(R)--CO 2 R*, CO 2 --(CH 2 ) n OCOR* where Ar 2 is independently taken from Ar, where m is as defined below, CONHCH(R)CO 2 R* where R is a side chain of aspartic or glutamic acid, R is hydrogen only when B is not a bond, --CO 2 CH 2 CH 2 N + (R*) 3 X 1- when X 1- is a pharmaceutically acceptable counter anion, A is --(CH 2 ) n CO--, --SO 2 --, --S(═O)--, --NHCO--, --(CH 2 ) n --C(═O)--, ##STR40## --O--(CH 2 ) n CO-- or --HC═CHCO-- wherein n is an integer from zero to six; R 2 is CH 3 ; R 3 and R 4 are each independently selected from hydrogen, R 2 and --(CH 2 ) n , --B--D wherein: n' is an integer of from zero to three; B is a bond, --OCO(CH 2 ) n --, --O(CH 2 ) n --, --NHCO(CH 2 ) n --, --CONH(CH 2 ) n --, --NHCOCH═CH--, --COO(CH 2 ) n --, --CO(CH 2 ) n --, --S--(CH 2 ) n --, --S(═)--(CH 2 ) n --, --SO 2 --(CH 2 ) n --, --NHSO 2 --(CH 2 ) n --, --SO 2 NH--(CH 2 ) n --, ##STR41## wherein R 7 and R 8 are each independently selected from hydrogen and R 2 or together form a ring (CH 2 ) m wherein m is an integer of from 1 to 5 and n is as defined above; D is hydrogen, --COOR*, --CH 2 NR 5 R*, --CHR 2 NR 5 R*, --CH 2 OR*, --CHR 2 OR*, --CH 2 SR*, --CHR 2 SR*, --CONR 5 R 6 , --CONR 5 R*, an acid replacement selected from ##STR42## wherein R*, R 2 , R 5 , and R 6 are as defined above; R 9 is hydrogen or a straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n CO 2 R*, --(CH 2 ) n NR 5 R*, wherein n, R * , and R 5 are as defined above or taken from R 3 ; R 12 and R 13 are each independently hydrogen or are each independently taken with R 3 and R 4 , respectively, to form a moiety doubly bonded to the carbon atom; and Ar is a mono- or polycyclic unsubstituted or substituted carbo- aromatic or carbo- hydroaromatic moiety.
Claim 3
Dependent Claim 20 words
A compound according to claim 1 wherein the cycloalkyl or polycycloalkyl has from about six to about ten carbon atoms.
Claim 4
Dependent Claim 27 words
A compound according to claim 1 wherein each substituent on the cycloalkyl or polycycloalkyl is independently R*, F, Cl, Br, OR*, NR 5 R*, CF 3 .
Claim 5
Dependent Claim 83 words
A compound according to claim 1 wherein the polycycloalkyl is selected from the group consisting of ##STR43## wherein W, X, Y, and Z are each independently hydrogen, a straight or branched alkyl of from one to six carbon atoms, CF 3 , NR 5 R 6 , --(CH 2 ) n CO 2 R*, CN, F, Cl, Br, OR*, SR*, wherein R*, R 5 and R 6 are as defined in claim 1 and n is an integer of from 1 to 3.
Claim 6
Dependent Claim 20 words
A compound according to claim 1 wherein A is --NHCO--, OC(═O)--, --SO 2 --, --S(═O)--, --SCO-- or --CH 2 CO--.
Claim 7
Dependent Claim 33 words
A compound according to claim 1 wherein Ar is an unsubstituted or substituted phenyl whose substituents are each independently selected from hydrogen, fluorine, chlorine, bromine, iodine, methyl, methoxy, trifluoromethyl, nitro, --NHCOCH2COOH, and --CH2CH2CO2H.
Claim 8
Dependent Claim 68 words
A compound according to claim 1 wherein: R 1 is 2-adamantyl or 1-(S)-2-endobornyl; A is --NHCO--, --OCO--, --SO 2 --, --S(═O)-- or --CH 2 CO--; R 2 is --CH 3 , --CH 2 CO 2 H or --CH 2 C.tbd.CH; R 3 is --(CH 2 ) n , --B--D or H; R 4 is --(CH 2 ) n , --B--D or H; R 9 is hydrogen or methyl.
Claim 9
Dependent Claim 75 words
A compound according to claim 1 wherein: R 1 is 2adamantyl or 1-(S)-2-endobornyl; A is --OC(═O)--; R 2 is --CH 3 ; R 3 is H, CH 2 OR*, CH 2 OCOCH 2 CH 2 CO 2 R*, CH 2 OCOCH═CHCO 2 R*, CH 2 NHCOCH 2 CH 2 CO 2 R*, or CH 2 NHCOCH═CHCO 2 R*, R 4 is H, --NHCOCH 2 CH 2 CO 2 R*([D] configuration) or NHCOCH═CHCO 2 R*([D] configuration).
Claim 10
Dependent Claim 16 words
A compound according to claim 1 named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxo, (2,2-dimethyl-1-oxopropoxy)methyl ester [R-(R*,R*)]--.
Claim 11
Dependent Claim 12 words
A compound named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]ethyl]amino]-4-oxo-, chloromethyl ester, [R-(R*,R*)]--.
Claim 12
Dependent Claim 12 words
A compound named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]ethyl]amino]-4-oxo-, chloromethyl ester, [R-(R*,R*)]--.
Claim 13
Dependent Claim 15 words
A compound according to claim 1 named Pentanedioic acid, [4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-1,4-dioxobutoxy]methyl ester, [R-(R*,R*)]--.
Claim 14
Dependent Claim 15 words
A compound according to claim 1 named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxo-2,3-dihydro-1H-inden-5-yl ester, [R-(R*,R*)]--.
Claim 15
Dependent Claim 16 words
A compound according to claim 1 named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxo-, 2-(diethylamino)ethyl ester [R-(R*,R*)]--.
Claim 16
Dependent Claim 13 words
A compound according to claim 1 named L-Aspartic acid, N-[N-[α-methyl-N-[(tricyclo[3.3.1.1 3 ,7 ]-dec-2-yloxy)carbonyl]-D-tryptophyl]-L-phenylalanyl]--.
Claim 17
Dependent Claim 13 words
A compound according to claim 1 named L-Glutamic acid, N-[N-[α-methyl-N-[(tricyclo[3.3.1.1 3 ,7 ]-dec-2-yloxy)carbonyl]-D-tryptophyl]-L-phenylalanyl]--.
Claim 18
Dependent Claim 15 words
A compound according to claim 1 named L-Glutamic acid, N-[N-[α-methyl-N-[(tricyclo[3.3.1.1 3 ,7 ]-dec-2-yloxy)carbonyl]-D-tryptophyl]-L-phenylalanyl]--, dimethyl ester.
Claim 19
Dependent Claim 68 words
A pharmaceutical composition comprising an amount of a compound according to claim 1 effective to treat gastrointestinal ulcers, psychotic behavior, to block the reaction caused by withdrawal from drug or alcohol use, to potentiate the effects of morphine or other opioids in treating pain, to suppress appetite, to reduce gastric acid secretion, to reduce anxiety, to treat and/or prevent panic in a mammal, and a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US4164571A Cited
US4997950A Cited
EP0405537A1 Cited
WO1991000274A1 Cited
US5278316A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-09-10 2000-03-11 2000-09-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-09-10 2004-03-11 2004-09-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-09-10 2008-03-11 2008-09-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag